FDA Warning Letter — Medlife Pharmacy and Compounding
The FDA took a Warning Letter action against Medlife Pharmacy and Compounding on April 30, 2020 (Irvine, CA). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.
Action Details
- Facility
- Medlife Pharmacy and Compounding
- Date
- April 30, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Center
- CDER
- Location
- Irvine, CA (United States)